Point-Of-Care Molecular Diagnostics Market Insights on Emerging Scope Prophesy

According to Future Market Insights' (FMI) point-of-care molecular diagnostics market survey, the market is expected to grow at an average rate of 8% from 2022 to 2032.

Many current point-of-care diagnostics are based on lateral flow immunoassay technology, and these instruments use antibodies to detect the presence of an analyte, such as cancer biomarkers, in a short period of time, thereby accelerating the growth of the point-of-care molecular diagnostics market.

According to the point-of-care molecular diagnostics market report, the growing trend toward preventive medicine is driving up demand for point-of-care molecular diagnostics. This is expected to significantly influence future trends in point-of-care molecular diagnostics.

According to UN data, the number of older adults has been steadily increasing for decades. As a result of this demographic shift, the prevalence of various chronic diseases is increasing, making point-of-care molecular diagnostics devices more appealing.

Current cancer diagnostic methods, according to the study, are invasive (for example, cystoscopy, which involves inserting a hollow tube/cystoscope equipped with a lens into the urethra and bladder to diagnose cancer). However, less invasive methods, such as point-of-care molecular tests, may be available for point-of-care cancer diagnostics, expanding the opportunities for point-of-care molecular diagnostics.

Read More@ https://www.futuremarketinsights.com/reports/point-of-care-molecular-diagnostics-market

Though the COVID-19 pandemic and the use of molecular diagnostic methods for COVID-19 testing reduced overall sales of molecular diagnostics in most industries, it had a positive impact on the point-of-care molecular diagnostics market size.

As countries gradually relax their travel restrictions, the number of people testing has increased. Aside from vaccines and therapeutic drugs, there is a growing demand for more precise and simple testing technologies, as well as the expansion of testing structures.

As a result, point-of-care molecular diagnostics companies have made strategic decisions to introduce POC rapid tests, maintain revenue, and reduce the impact of COVID-19 on their operational capabilities. This market trend for point-of-care molecular diagnostics is expected to continue in the coming years.

Aside from cancer in the elderly, respiratory diseases in children and adults are quickly becoming one of the top five killers. According to Pfizer, there are currently no RSV immunisation options available, despite the fact that many vaccines are still in clinical trials.

People are dying as a result of this because they are not aware of the available treatment. As a result, the availability of point-of-care molecular diagnostic tests is critical for rapid analysis and, as a result, providing patients with immediate treatment.

Because of the aforementioned factors, the point-of-care molecular diagnostics market is expected to generate approximately US$ 4 billion by 2026.

Key Players in the Point-Of-Care Molecular Diagnostics Market are:

Danaher Corporation (US), Alere Inc. (US), Quidel Corporation (US), Biocartis Group NV (Belgium), bioMérieux SA (France), Thermo Fisher Scientific (US), Mesa Biotech Inc. (US), F. Hoffmann-La Roche Ltd., and Meridian Bioscience Inc. (US) are the critical point-of-care diagnostic companies profiled in the global POC molecular diagnostics market.

Comments

Post a Comment

Popular posts from this blog

Portable Oxygen Concentrators Market | Innovative and Technological Advancement

Image
The global  portable oxygen concentrators market  is anticipated to witness lucrative growth opportunities over the forecast period from 2022 and 2032, with a phenomenal CAGR of 10.1%. The market is expected to enjoy a valuation of US$ 1.9 Billion by the end of the year 2022 and surpass a projection of US$ 5.0 Billion by the year 2032. According to the Future Market Insights historical analysis, the pulse flows portable oxygen concentrators were leading the market with a share of about 67.7% in the year 2021, within the global market. In the year 2021, the market value for portable oxygen concentrators was around 54.8% of the overall US$ 3.5 Billion of the global oxygen concentrators market. Portable oxygen concentrators supply oxygen to those patients who are suffering from respiratory diseases such as chronic obstructive pulmonary disease. In this process, nitrogen and oxygen are separated from the air in the environment with the help of the concentrator which then discards ...
Read more

Helicobacter Pylori Infections Treatment Market Research and Analysis 2023 to 2033

Image
The global helicobacter pylori infections treatment market is predicted to reach US$ 638.3 Million in 2023, with a compound annual growth rate (CAGR) of 7.04% anticipated from 2023 to 2033, reaching US$ 1,260 Million. The spread of such infections can be attributed to a number of factors, including a lack of adequate water supply, poor sanitation, a large population, and poor personal hygiene. One of the factors influencing the Helicobacter pylori diagnostics market's growth is increased awareness of H. pylori infections in the cohort. Antibiotic availability and affordability, as well as quicker processing times, will boost antibiotic use and the need for pre and post-surveillance tests. Furthermore, rising H. pylori infection rates, the need for early symptom diagnosis, and technological advances in diagnostic methods are expected to fuel overall growth over the forecast period. The key drivers of the industry are the increasing prevalence of communicable diseases and rising pub...
Read more

Pediatric Clinical Trials Market size is set to Grow at a Remarkable Pace by 2032

Image
During the forecast period 2022 to 2032, the global pediatric clinical trials market  is expected to grow at a value of 5.3%, according to Future Market Insights. In 2022, this market was predicted to have a global valuation of US$ 15.8 Billion, and is expected to reach a sum of US$ 26.47 Billion by 2032. The market is going to face increasing demand owing to the increase of pediatric chronic and genetic diseases all across the world. The growing need for novel vaccines and biopharmaceuticals to treat infectious diseases such as measles, polio, tuberculosis, rubella, influenza, mumps, whooping cough, malaria, chickenpox, and staphylococcus pharyngitis is expected to drive market growth. At the same time, diabetes is a big worry among today's children. The market is being driven by rising parental awareness of children clinical trials for severe infections and chronic diseases, as well as a large number of CROs doing pediatric research. In 2021, the onc...
Read more